| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cardiff Oncology, Inc. | Director | Common Stock | 1,345,676 | $3,296,906 | $2.45 | 30 Jul 2025 | By minor child |
| Cardiff Oncology, Inc. | Director | Common Stock | 1,330,676 | $3,260,156 | $2.45 | 30 Jul 2025 | Direct |
| Pacira BioSciences, Inc. | Director | Common Stock | 22,127 | $677,086 | $30.60 | 08 Mar 2024 | Direct |
| Pacira BioSciences, Inc. | Director | Stock Option (Right to Buy) | 12,925 | $343,676 | $26.59 | 14 Jun 2023 | Direct |
| Cardiff Oncology, Inc. | Director | Stock Options | 187,539 | 26 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRDF | Cardiff Oncology, Inc. | 30 Jul 2025 | 2 | +$710,500 | 4 | Director | 31 Jul 2025, 16:05 |
| CRDF | Cardiff Oncology, Inc. | 26 Jun 2025 | 1 | $0 | 4 | Director | 27 Jun 2025, 19:38 |
| CRDF | Cardiff Oncology, Inc. | 11 Dec 2024 | 2 | +$940,199 | 4 | Director | 12 Dec 2024, 16:05 |
| CRDF | Cardiff Oncology, Inc. | 27 Jun 2024 | 1 | $0 | 4 | Director | 01 Jul 2024, 16:09 |
| PCRX | Pacira BioSciences, Inc. | 06 Mar 2024 | 3 | -$3,656,226 | 4 | Director | 08 Mar 2024, 17:33 |
| CRDF | Cardiff Oncology, Inc. | 19 Dec 2023 | 1 | +$41,100 | 4 | Director | 19 Dec 2023, 18:39 |
| CRDF | Cardiff Oncology, Inc. | 10 Nov 2023 | 1 | +$22,491 | 4 | Director | 14 Nov 2023, 16:24 |
| CRDF | Cardiff Oncology, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 17:04 |
| PCRX | Pacira BioSciences, Inc. | 14 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 17:36 |
| PCRX | Pacira BioSciences, Inc. | 11 May 2023 | 3 | -$227 | 4 | Director | 15 May 2023, 18:53 |
| CRDF | Cardiff Oncology, Inc. | 15 Sep 2022 | 1 | +$256,500 | 4 | Director | 19 Sep 2022, 08:37 |
| PCRX | Pacira BioSciences, Inc. | 08 Jun 2022 | 2 | $0 | 4 | Director | 08 Jun 2022, 19:37 |
| CRDF | Cardiff Oncology, Inc. | 09 Mar 2022 | 1 | $0 | 4 | Director | 11 Mar 2022, 13:11 |
| PCRX | Pacira BioSciences, Inc. | 03 Mar 2022 | 2 | +$75,670 | 4 | Director | 07 Mar 2022, 19:07 |
| PCRX | Pacira BioSciences, Inc. | 28 Feb 2022 | 10 | -$1,675,550 | 4 | Director | 01 Mar 2022, 17:03 |
| CRDF | Cardiff Oncology, Inc. | 21 Sep 2021 | 1 | +$202,500 | 4 | Director | 22 Sep 2021, 17:54 |
| CRDF | Cardiff Oncology, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 16:13 |
| PCRX | Pacira BioSciences, Inc. | 13 May 2021 | 3 | $0 | 4 | Director | 11 Jun 2021, 20:47 |